Are you Dr. Kashani-Sabet?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2340 Clay St
San Francisco, CA 94115Phone+1 415-600-3800Fax+1 415-600-3865
Summary
- Dr. Mohammed Kashani-Sabet, MD is a board certified dermatologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with California Pacific Medical Center.
Education & Training
University of California (San Francisco)Residency, Dermatology, 1992 - 1995
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 1991 - 1992
Stony Brook University Health Sciences Center School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1993 - 2026- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690 Start of enrollment: 2011 Feb 08
Publications & Presentations
PubMed
- 3 citationsThe Molecular Evolution of Melanoma Distant Metastases.Vladimir Bezrookove, Sara Kianian, Lea McGeever, Robyn Jones, Chongshan Caressi
The Journal of Investigative Dermatology. 2024-11-01 - miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK.Vladimir Bezrookove, Imran Khan, Anukana Bhattacharjee, Juifang Fan, Robyn Jones
Journal of Translational Medicine. 2024-08-13 - Preoperative and Intraoperative Identification of Sentinel Lymph Nodes in Melanoma Surgery.Stanley P Leong, Mehdi Nosrati, Max C Wu, Donald M Torre, Ted F Bartley
Cancers. 2024-08-05
Press Mentions
New Study Generates Predictive Model to Help Identify Melanoma Patients Best Eligible for Sentinel Lymph Node BiopsyApril 19th, 2023
Professional Memberships
- Fellow
